Skip to main content

Advertisement

SpringerLink
Log in

Integrated Care Model of Adiposity-Related Chronic Diseases

  • Hypertension and Obesity (E Reisin, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Although obesity is a disease, most patients with obesity do not undergo effective treatment nor adhere to long-term care. We examine the barriers that patients with obesity confront when searching for effective treatment and propose an integrated care model of adiposity-related chronic diseases in a cardio-renal metabolic unit.

Recent Findings

The current care of obesity is fragmented between primary care providers, medical specialists and metabolic bariatric surgeons with little or no coordination of care between these providers. The current care of obesity heavily focuses on weight loss as the primary aim of treatment thereby reenforcing the weight stigma and turning patients away from effective therapy like metabolic bariatric surgery.

Summary

An interdisciplinary cardio-renal metabolic unit that, besides weight loss, emphasizes prevention/remission of adiposity-related chronic diseases may deliver thorough and rewarding care to most patients with obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. State-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440–50.

  2. Ogden CL, Fryar CD, Martin CB, et al. Trends in obesity prevalence by race and Hispanic origin-1999-2000 to 2017–2018. JAMA. 2020;324(12):1208–10.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523–9.

    Article  CAS  PubMed  Google Scholar 

  4. Bays HE, Chapman RH, Grandy S, Group SI. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract. 2007;61(5):737–47.

    Article  Google Scholar 

  5. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world–a growing challenge. N Engl J Med. 2007;356(3):213–5.

    Article  CAS  PubMed  Google Scholar 

  6. Stenholm S, Head J, Aalto V, et al. Body mass index as a predictor of healthy and disease-free life expectancy between ages 50 and 75: a multicohort study. Int J Obes (Lond). 2017;41(5):769–75.

    Article  CAS  Google Scholar 

  7. Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3(4):280–7.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kitahara CM, Flint AJ, Berrington de Gonzalez A, et al. Association between class III obesity (BMI of 40–59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med. 2014;11(7):e1001673.

  9. Global Burden of Metabolic Risk Factors for Chronic Diseases C, Lu Y, Hajifathalian K, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383(9921):970–83.

  10. Kyle TK, Dhurandhar EJ, Allison DB. Regarding obesity as a disease: evolving policies and their implications. Endocrinol Metab Clin North Am. 2016;45(3):511–20.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Yanovski SZ, Yanovski JA. Progress in Pharmacotherapy for Obesity. JAMA. 2021;326(2):129–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Burguera B, Schauer P, Kahan S. What to offer the 99% of patients with severe obesity who do not undergo bariatric surgery? Mayo Clin Proc. 2019;94(6):957–60.

    Article  PubMed  Google Scholar 

  13. Mawardi G, Kirkland EB, Zhang J, et al. Patient perception of obesity versus physician documentation of obesity: a quality improvement study. Clin Obes. 2019;9(3): e12303.

    Article  PubMed  Google Scholar 

  14. Lemay CA, Cashman S, Savageau J, Fletcher K, Kinney R, Long-Middleton E. Underdiagnosis of obesity at a community health center. J Am Board Fam Pract. 2003;16(1):14–21.

    Article  PubMed  Google Scholar 

  15. Lumsden RH, Pagidipati NJ, Phelan MP, Chiswell K, Peterson ED. Prevalence and management of adult obesity in a large U.S. academic health system. Am J Prev Med. 2020;58(6):817–24.

  16. Pantalone KM, Hobbs TM, Chagin KM, et al. Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system. BMJ Open. 2017;7(11): e017583.

    Article  PubMed  PubMed Central  Google Scholar 

  17. McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139(11):933–49.

  18. Moyer VA, Force USPST. Behavioral counseling interventions to promote a healthful diet and physical activity for cardiovascular disease prevention in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(5):367–71.

  19. Force USPST, Curry SJ, Krist AH, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US preventive services task force recommendation statement. JAMA. 2018;320(11):1163–71.

  20. Appel LJ, Clark JM, Yeh HC, et al. Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med. 2011;365(21):1959–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. LeBlanc ES, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US preventive services task force. JAMA. 2018;320(11):1172–91.

    Article  PubMed  Google Scholar 

  22. Felix H, West DS, Bursac Z. Impact of USPSTF practice guidelines on clinician weight loss counseling as reported by obese patients. Prev Med. 2008;47(4):394–7.

    Article  PubMed  Google Scholar 

  23. Petrin C, Kahan S, Turner M, Gallagher C, Dietz WH. Current attitudes and practices of obesity counselling by health care providers. Obes Res Clin Pract. 2017;11(3):352–9.

    Article  PubMed  Google Scholar 

  24. Kraschnewski JL, Sciamanna CN, Stuckey HL, et al. A silent response to the obesity epidemic: decline in US physician weight counseling. Med Care. 2013;51(2):186–92.

    Article  PubMed  Google Scholar 

  25. Gero D, Hulesch B, Bueter M. Mindset and Communication Barriers in the Diffusion of Bariatric Surgery. Curr Atheroscler Rep. 2018;20(8):38.

    Article  PubMed  Google Scholar 

  26. Kushner RF, Butsch WS, Kahan S, Machineni S, Cook S, Aronne LJ. Obesity coverage on medical licensing examinations in the United States. What Is Being Tested? Teach Learn Med. 2017;29(2):123–8.

  27. Bretches MP, Schwasinger-Schmidt TE. The state of obesity in Kansas: a community based approach to chronic care management. Kans J Med. 2021;14:21–8.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Primomo JA, Kajese T, Davis G, et al. Decreased access to bariatric care: an analysis of referral practices to bariatric specialists. Surg Obes Relat Dis. 2016;12(9):1725–30.

    Article  PubMed  Google Scholar 

  29. Tork S, Meister KM, Uebele AL, et al. Factors Influencing Primary Care Physicians' Referral for Bariatric Surgery. JSLS. 2015;19(3).

  30. Avidor Y, Still CD, Brunner M, Buchwald JN, Buchwald H. Primary care and subspecialty management of morbid obesity: referral patterns for bariatric surgery. Surg Obes Relat Dis. 2007;3(3):392–407.

    Article  PubMed  Google Scholar 

  31. Glauser TA, Roepke N, Stevenin B, Dubois AM, Ahn SM. Physician knowledge about and perceptions of obesity management. Obes Res Clin Pract. 2015;9(6):573–83.

    Article  PubMed  Google Scholar 

  32. Bray GA, Heisel WE, Afshin A, et al. The science of obesity management: an endocrine society scientific statement. Endocr Rev. 2018;39(2):79–132.

    Article  PubMed  PubMed Central  Google Scholar 

  33. •• Heymsfield SB, Wadden TA. Mechanisms, Pathophysiology, and Management of Obesity. N Engl J Med. 2017;376(3):254–66. A concise and straightforward review of obesity.

  34. Elangovan A, Shah R, Smith ZL. Pharmacotherapy for obesity-trends using a population level national database. Obes Surg. 2021;31(3):1105–12.

    Article  PubMed  Google Scholar 

  35. Mauer Y, Parker M, Kashyap SR. Antiobesity drug therapy: an individualized and comprehensive approach. Cleve Clin J Med. 2021;88(8):440–8.

    Article  PubMed  Google Scholar 

  36. Kanj A, Levine D. Overcoming obesity: weight-loss drugs are underused. Cleve Clin J Med. 2020;87(10):602–4.

    Article  PubMed  Google Scholar 

  37. Shi Q, Wang Y, Hao Q, et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. Lancet. 2022;399(10321):259–69.

    Article  CAS  PubMed  Google Scholar 

  38. Boye KS, Lage MJ, Shinde S, Thieu V, Bae JP. Trends in HbA1c and body mass index among individuals with type 2 diabetes: evidence from a US Database 2012–2019. Diabetes Ther. 2021;12(7):2077–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Fan W, Song Y, Inzucchi SE, et al. Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry. Diabetes Obes Metab. 2019;21(5):1121–7.

    Article  CAS  PubMed  Google Scholar 

  40. Puhl RM, Brownell KD. Psychosocial origins of obesity stigma: toward changing a powerful and pervasive bias. Obes Rev. 2003;4(4):213–27.

    Article  CAS  PubMed  Google Scholar 

  41. Andreyeva T, Puhl RM, Brownell KD. Changes in perceived weight discrimination among Americans, 1995–1996 through 2004–2006. Obesity (Silver Spring). 2008;16(5):1129–34.

    Article  Google Scholar 

  42. •• Rubino F, Puhl RM, Cummings DE, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26(4):485–97. The paper underlies the importance of weight stigma in obesity.

  43. Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984–1010.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Piche ME, Tchernof A, Despres JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477–500.

    Article  CAS  PubMed  Google Scholar 

  45. Boido A, Ceriani V, Cetta F, Lombardi F, Pontiroli AE. Bariatric surgery and prevention of cardiovascular events and mortality in morbid obesity: mechanisms of action and choice of surgery. Nutr Metab Cardiovasc Dis. 2015;25(5):437–43.

    Article  CAS  PubMed  Google Scholar 

  46. Chao GF, Diaz A, Ghaferi AA, Dimick JB, Byrnes ME. Understanding racially diverse community member views of obesity stigma and bariatric surgery. Obes Surg. 2022;32(4):1216–26.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Cohen R, Newton-John T, Slater A. The case for body positivity on social media: Perspectives on current advances and future directions. J Health Psychol. 2021;26(13):2365–73.

    Article  PubMed  Google Scholar 

  48. Muttarak R. Normalization of Plus Size and the Danger of Unseen Overweight and Obesity in England. Obesity (Silver Spring). 2018;26(7):1125–9.

    Article  Google Scholar 

  49. Penney TL, Kirk SF. The Health at Every Size paradigm and obesity: missing empirical evidence may help push the reframing obesity debate forward. Am J Public Health. 2015;105(5):e38-42.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Verhaak AMS, Ferrand J, Puhl RM, Tishler DS, Papasavas PK, Umashanker D. Experienced weight stigma, internalized weight bias, and clinical attrition in a medical weight loss patient sample. Int J Obes (Lond). 2022.

  51. Ricci MA, De Vuono S, Scavizzi M, Gentili A, Lupattelli G. Facing Morbid Obesity: How to Approach It. Angiology. 2016;67(4):391–7.

    Article  CAS  PubMed  Google Scholar 

  52. Campos GM, Khoraki J, Browning MG, Pessoa BM, Mazzini GS, Wolfe L. Changes in utilization of bariatric surgery in the United States from 1993 to 2016. Ann Surg. 2020;271(2):201–9.

    Article  PubMed  Google Scholar 

  53. Zevin B, Dalgarno N, Martin M, et al. Barriers to accessing weight-loss interventions for patients with class II or III obesity in primary care: a qualitative study. CMAJ Open. 2019;7(4):E738–44.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Barber D, Morkem R, Dalgarno N, et al. Patients eligible and referred for bariatric surgery in southeastern Ontario: retrospective cohort study. Can Fam Physician. 2021;67(1):e31–40.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Lopez EKH, Helm MC, Gould JC, Lak KL. Primary care providers’ attitudes and knowledge of bariatric surgery. Surg Endosc. 2020;34(5):2273–8.

    Article  PubMed  Google Scholar 

  56. Funk LM, Jolles SA, Greenberg CC, et al. Primary care physician decision making regarding severe obesity treatment and bariatric surgery: a qualitative study. Surg Obes Relat Dis. 2016;12(4):893–901.

    Article  PubMed  Google Scholar 

  57. Imbus JR, Voils CI, Funk LM. Bariatric surgery barriers: a review using Andersen’s Model of Health Services Use. Surg Obes Relat Dis. 2018;14(3):404–12.

    Article  PubMed  Google Scholar 

  58. Dolan P, Afaneh C, Symer M, Dakin GF, Pomp A, Yeo H. Assessment of public attitudes toward weight loss surgery in the United States. JAMA Surg. 2019;154(3):264–6.

    Article  PubMed  Google Scholar 

  59. Pearl RL, Wadden TA, Walton K, Allison KC, Tronieri JS, Williams NN. Health and appearance: Factors motivating the decision to seek bariatric surgery. Surg Obes Relat Dis. 2019;15(4):636–42.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Zevin B, Martin M, Dalgarno N, et al. Survey of perceptions and educational needs of primary care providers regarding management of patients with class II and III obesity in Ontario, Canada. BMC Fam Pract. 2021;22(1):14.

    Article  PubMed  PubMed Central  Google Scholar 

  61. van Veldhuisen SL, Gorter TM, van Woerden G, et al. Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis. Eur Heart J. 2022;43(20):1955–69.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Bramante C, Wise E, Chaudhry Z. Care of the patient after metabolic and bariatric surgery. Ann Intern Med. 2022;175(5):ITC65-ITC80.

  63. Altieri MS, Irish W, Pories WJ, Shah A, DeMaria EJ. Examining the rates of obesity and bariatric surgery in the United States. Obes Surg. 2021;31(11):4754–60.

    Article  PubMed  Google Scholar 

  64. Hanipah ZN, Schauer PR. Bariatric surgery as a long-term treatment for type 2 diabetes/metabolic syndrome. Annu Rev Med. 2020;71:1–15.

    Article  CAS  PubMed  Google Scholar 

  65. Pareek M, Bhatt DL, Schiavon CA, Schauer PR. Metabolic Surgery for Hypertension in Patients With Obesity. Circ Res. 2019;124(7):1009–24.

    Article  CAS  PubMed  Google Scholar 

  66. Morgan DJ, Ho KM, Armstrong J, Litton E. Long-term clinical outcomes and health care utilization after bariatric surgery: a population-based study. Ann Surg. 2015;262(1):86–92.

    Article  PubMed  Google Scholar 

  67. Canner JK, Kaslow SR, Gani F, et al. Incidence of and risk factors associated with care fragmentation following bariatric surgery. Surg Obes Relat Dis. 2019;15(7):1170–81.

    Article  PubMed  Google Scholar 

  68. Lazzati A, Chatellier G, Paolino L, Batahei S, Katsahian S. Postoperative care fragmentation in bariatric surgery and risk of mortality: a nationwide study. Surg Obes Relat Dis. 2021;17(7):1327–33.

    Article  PubMed  Google Scholar 

  69. El Chaar M. How can we shape our future as bariatric surgeons and win the fight against obesity in an ever-changing healthcare industry? Surg Obes Relat Dis. 2021;17(2):466–8.

    Article  PubMed  Google Scholar 

  70. Tsai AG, Bessesen DH. Obesity. Ann Intern Med. 2019;170(5):ITC33-ITC48.

  71. Haskins IN. Comment on: emergency department encounters, hospital admissions, course of treatment, and follow-up care for behavioral health concerns in patients after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2021;17(10):e50–1.

    Article  PubMed  Google Scholar 

  72. Hua Y, Lou YX, Li C, Sun JY, Sun W, Kong XQ. Clinical outcomes of bariatric surgery - Updated evidence. Obes Res Clin Pract. 2022;16(1):1–9.

    Article  PubMed  Google Scholar 

  73. Hall JE, Mouton AJ, da Silva AA, et al. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res. 2021;117(8):1859–76.

    Article  CAS  PubMed  Google Scholar 

  74. Larjani S, Spivak I, Hao Guo M, et al. Preoperative predictors of adherence to multidisciplinary follow-up care postbariatric surgery. Surg Obes Relat Dis. 2016;12(2):350–6.

    Article  PubMed  Google Scholar 

  75. Shibuya K, Ji X, Pfoh ER, et al. Association between shared medical appointments and weight loss outcomes and anti-obesity medication use in patients with obesity. Obes Sci Pract. 2020;6(3):247–54.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Reiter-Brennan C, Dzaye O, Davis D, Blaha M, Eckel RH. Comprehensive care models for cardiometabolic disease. Curr Cardiol Rep. 2021;23(3):22.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Rives-Lange C, Rassy N, Carette C, et al. Seventy years of bariatric surgery: a systematic mapping review of randomized controlled trials. Obes Rev. 2022;23(5): e13420.

    Article  PubMed  Google Scholar 

  78. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376(7):641–51.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397(10271):293–304.

    Article  PubMed  Google Scholar 

  80. Courcoulas AP, Gallagher JW, Neiberg RH, et al. Bariatric surgery vs lifestyle intervention for diabetes treatment: 5-year outcomes from a randomized trial. J Clin Endocrinol Metab. 2020;105(3).

  81. Schiavon CA, Bhatt DL, Ikeoka D, et al. Three-year outcomes of bariatric surgery in patients with obesity and hypertension : a randomized clinical trial. Ann Intern Med. 2020;173(9):685–93.

    Article  PubMed  Google Scholar 

  82. Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.

    Article  CAS  PubMed  Google Scholar 

  83. Syn NL, Cummings DE, Wang LZ, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet. 2021;397(10287):1830–41.

    Article  PubMed  Google Scholar 

  84. Mentias A, Aminian A, Youssef D, et al. Long-term cardiovascular outcomes after bariatric surgery in the medicare population. J Am Coll Cardiol. 2022;79(15):1429–37.

    Article  PubMed  Google Scholar 

  85. Bouchard P, Al-Masrouri S, Demyttenaere S, Court O, Andalib A. Long-term impact of bariatric surgery on major adverse cardiovascular events in patients with obesity, diabetes and hypertension: a population-level study. Obes Surg. 2022;32(3):771–8.

    Article  PubMed  Google Scholar 

  86. Schauer PR, Nissen SE. After 70 years, metabolic surgery has earned a cardiovascular outcome trial. Circulation. 2021;143(15):1481–3.

    Article  PubMed  Google Scholar 

  87. Cypess AM. Reassessing human adipose tissue. N Engl J Med. 2022;386(8):768–79.

    Article  CAS  PubMed  Google Scholar 

  88. Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–9.

    Article  PubMed  Google Scholar 

  89. Pareek M, Schauer PR, Kaplan LM, Leiter LA, Rubino F, Bhatt DL. Metabolic surgery: weight loss, diabetes, and beyond. J Am Coll Cardiol. 2018;71(6):670–87.

    Article  PubMed  Google Scholar 

  90. Jimenez A, Pane A, Ibarzabal A, et al. Weight-loss thresholds after bariatric surgery and cardiovascular outcomes: more is better. Int J Obes (Lond). 2022;46(2):279–86.

    Article  Google Scholar 

  91. Muller TD, Bluher M, Tschop MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2022;21(3):201–23.

    Article  PubMed  Google Scholar 

  92. Goncalves E, Bell DSH. Combination treatment of SGLT2 inhibitors and GLP-1 receptor agonists: symbiotic effects on metabolism and cardiorenal risk. Diabetes Ther. 2018;9(3):919–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. •• Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022. The findings of Tirzepatide randomized controlled trial.

  94. Laferrere B, Pattou F. Weight-independent mechanisms of glucose control after Roux-en-Y gastric bypass. Front Endocrinol (Lausanne). 2018;9:530.

    Article  Google Scholar 

  95. Cummings DE, Rubino F. Metabolic surgery for the treatment of type 2 diabetes in obese individuals. Diabetologia. 2018;61(2):257–64.

    Article  PubMed  Google Scholar 

  96. Lawler H, Salehi M. Diabetes Remission After Gastric Bypass: To Be or Not to Be Dependent on Weight Loss. J Clin Endocrinol Metab. 2021;106(5):e2362–4.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Samson R, Milligan G, Lewine E, et al. Effect of sleeve gastrectomy on hypertension. J Am Soc Hypertens. 2018;12(11):e19–25.

    Article  PubMed  Google Scholar 

  98. •• Aminian A, Zajichek A, Tu C, et al. How much weight loss is required for cardiovascular benefits? Insights from a metabolic surgery matched-cohort study. Ann Surg. 2020;272(4):639–45. An important discussion of relationship between weight loss and health improvement.

  99. Prospective Studies C, Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.

    Article  Google Scholar 

  100. Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6(12):944–53.

  101. d’Errico M, Pavlova M, Spandonaro F. The economic burden of obesity in Italy: a cost-of-illness study. Eur J Health Econ. 2022;23(2):177–92.

    Article  PubMed  Google Scholar 

  102. Saxon DR, Reiter-Brennan C, Blaha MJ, Eckel RH. Cardiometabolic medicine: development of a new subspecialty. J Clin Endocrinol Metab. 2020;105(7).

  103. •• Bluher M. Metabolically healthy obesity. Endocr Rev. 2020;41(3). A seminal review of metabolically healthy and unhealthy obesity.

  104. Magkos F. Metabolically healthy obesity: what’s in a name? Am J Clin Nutr. 2019;110(3):533–9.

    Article  PubMed  Google Scholar 

  105. Roberson LL, Aneni EC, Maziak W, et al. Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality – a systematic review. BMC Public Health. 2014;14:14.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–69.

    Article  PubMed  Google Scholar 

  107. Lehn-Stefan A, Peter A, Machann J, et al. Impaired metabolic health and low cardiorespiratory fitness independently associate with subclinical atherosclerosis in obesity. J Clin Endocrinol Metab. 2022;107(6):e2417–24.

    Article  PubMed  Google Scholar 

  108. Stefan N, Haring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019;7(4):313–24.

    Article  PubMed  Google Scholar 

  109. Boonchaya-anant P, Apovian CM. Metabolically healthy obesity–does it exist? Curr Atheroscler Rep. 2014;16(10):441.

    Article  PubMed  Google Scholar 

  110. Palau-Rodriguez M, Garcia-Aloy M, Minarro A, et al. Effects of a long-term lifestyle intervention on metabolically healthy women with obesity: metabolite profiles according to weight loss response. Clin Nutr. 2020;39(1):215–24.

    Article  CAS  PubMed  Google Scholar 

  111. Kantartzis K, Machann J, Schick F, et al. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia. 2011;54(4):864–8.

    Article  CAS  PubMed  Google Scholar 

  112. Mehta M, Istfan NW, Apovian CM. Obesity: overview of weight management. Endocr Pract. 2021;27(6):626–35.

    Article  PubMed  Google Scholar 

  113. Cambi MPC, Baretta GAP, Magro DO, et al. Multidisciplinary approach for weight regain-how to manage this challenging condition: an expert review. Obes Surg. 2021;31(3):1290–303.

    Article  PubMed  Google Scholar 

  114. O’Brien PE, Hindle A, Brennan L, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29(1):3–14.

    Article  PubMed  Google Scholar 

  115. Coelho C, Crane J, Agius R, McGowan B. The bariatric-metabolic physician’s role in managing clinically severe obesity. Curr Obes Rep. 2021;10(3):263–73.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Gasmi A, Bjorklund G, Mujawdiya PK, et al. Micronutrients deficiences in patients after bariatric surgery. Eur J Nutr. 2022;61(1):55–67.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Cardiology, John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA

    Thierry H. Le Jemtel & Rohan Samson

  2. Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

    Suzanne Oparil

Authors
  1. Thierry H. Le Jemtel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rohan Samson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Suzanne Oparil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thierry H. Le Jemtel.

Ethics declarations

Conflict of Interest

Rohan Samson, Pierre Vladimir Ennezat, and Thierry H. Le Jemtel declare that they have no conflict of interest. Suzanne Oparil reports personal fees from Preventric Diagnostic, Inc., personal fees from CinCor Pharma Inc., grants from HIGI, grants from George Clinical Pty, grants from CinCor, outside the submitted work: and EIC, Current Hypertension Reports (Journal; Publisher—Springer Science Business Media LLC); annual stipend of $5000 (Springer); Editor-in-Chief Term until December 2022.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Hypertension and Obesity

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Le Jemtel, T.H., Samson, R. & Oparil, S. Integrated Care Model of Adiposity-Related Chronic Diseases. Curr Hypertens Rep 24, 563–570 (2022). https://doi.org/10.1007/s11906-022-01223-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-022-01223-3

Keywords

Search

Navigation